Videos

Arun K. Ghosh. professor of organic and medicinal chemistry at Purdue University, talks with Hiroaki Mitsuya, Head of Experimental Retrovirology Section at the National Cancer Institute, about HIV drug development.

Dr. Paul Richardson discusses promising drugs in the pipeline for the treatment of myeloma and new combination treatments using older drugs.

This video describes the use of targeted therapies for the treatment of multiple myeloma.

Are corticosteroids still the number one drug for inducing clinical remission in IBD?

This is the first webcast series from the Crohn's & Colitis Foundation of America targeted to health care professionals.

Video from the National Multiple Sclerosis Society with the message, "MS Kills Connection. Connection Kills MS."

This study discusses various treatments for multiple sclerosis, with a specific focus on alternative strategies like CCSVI.

This video summarizes the research findings from ECTRIMS 2012.

This video, from the Cleveland Clinic, discusses a syndrome in which generally healthy people who drink more than usual at the holidays can experience heart problems.

A discussion of an FDA warning regarding the potential for cognitive problems and elevated blood sugar associated with taking statins.

Doug Long, vice president of industry relations at IMS Health, discusses his predictions for the 2012-2013 flu season.

Several melanoma experts discuss new treatments for the condition, including vemurafenib (Zelboraf) and ipilimumab (Yervoy).

Isaac Brownell, MD, PhD, of Memorial Sloan-Kettering Cancer Center, discusses means of preventing and detecting skin cancers, including basal cell carcinoma, squamous cell carcinoma, and melanoma.

Dana Goldman, PhD discusses the results of a Journal of the American Medical Association study analyzing the effects of cost increases in children's asthma medication.